{"id":"W4205594263","doi":"10.1017/cjn.2021.314","title":"P.032 Long-term safety and tolerability of eptinezumab in patients with chronic migraine: A 2-year, open-label, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Discontinuation; Migraine; Upper respiratory tract infection; Placebo; Dosing; Internal medicine; Respiratory tract infections; Pediatrics; Anesthesia; Respiratory system","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00120489,0.0008273039,0.0008395663,0.0001487393,0.000407224,0.0007813873,0.0003809097,0.001358647,0.006735098],"category_scores_gemma":[0.0007041965,0.0002832621,0.000911954,0.0002007334,0.000551294,0.0006154772,0.0002172321,0.001973598,0.00122484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003662283,"about_ca_system_score_gemma":0.0007327896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003734367,"about_ca_topic_score_gemma":0.0007272554,"domain_scores_codex":[0.9997353,0.0001070831,0.00002056038,0.00004617157,0.00003483777,0.00005598643],"domain_scores_gemma":[0.9995064,0.0001009194,0.0001368462,0.00002587674,0.00004606917,0.0001838785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8532296,0.02640768,0.01567017,0.0008937799,0.001242596,0.0004664999,0.0002495882,0.0006065922,0.01635684,0.0001929511,0.005999919,0.07868374],"study_design_scores_gemma":[0.6839829,0.2752011,0.03337373,0.0000649545,0.0004553903,0.0004705773,0.00006697058,0.001114971,0.001470704,0.000184691,0.003592065,0.00002199482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915794,0.002376378,0.0002902843,0.000741592,0.0001383262,0.001351965,0.0007367719,0.00006899205,0.002716224],"genre_scores_gemma":[0.9928703,0.000860822,0.0007109409,0.0009389289,0.0002534507,0.001396063,0.0007533614,0.00001181057,0.002204332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006735098,"threshold_uncertainty_score":0.02253109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0481217116506347,"score_gpt":0.3252271883715348,"score_spread":0.2771054767209001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}